The feasibility of pathogenetic therapy for chronic viral hepatitis C in adult HIV-infected patients
In the third decade of the XXI century, HIV infection and viral hepatitis C remain urgent problems of modern medicine. Only in the Russian Federation in 2023, more than 1.6 million HIV-infected people and about 2 million patients with chronic viral hepatitis C are registered. Patients with a combine...
Saved in:
Main Authors: | E. B. Bun'kova, N. A. Bileva, M. I. Sinel'nikov, A. E. Bilev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2024-09-01
|
Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
Subjects: | |
Online Access: | https://vestnik.reaviz.ru/jour/article/view/985 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01) -
Application of Hepatoprotector Remaxol in the Treatment of Patients Co-Infected with Tuberculosis, HIV, and Chronic Hepatitis C
by: YU. G. Pritulina, et al.
Published: (2020-05-01) -
Evaluating the Fiscal Impact of Antiretroviral Therapy for the Management of HIV in the United States 1987–2023
by: Paquete AT, et al.
Published: (2025-05-01) -
HIV drug resistance and its associated factors among patients during interruption of antiretroviral therapy in China
by: Zhongbao Zuo, et al.
Published: (2025-07-01) -
Socio-Epidemiological and Clinical-Laboratory Characteristics of Patients with HIV and Chronic Hepatitis B+D
by: E. B. Yastrebova, et al.
Published: (2025-06-01)